Quantcast

Philly Leader

Monday, April 14, 2025

Discovery of TMEM65's role in calcium transport may aid heart and Alzheimer's treatments

Webp mnryxojbh3d8c01d3o6wgch6zqhj

Rebecca Armbruster, DO, MS, FACOI: Chief Medical Officer | Jeanes Hospital

Rebecca Armbruster, DO, MS, FACOI: Chief Medical Officer | Jeanes Hospital

Calcium transport in mitochondria is essential for cellular energy production and cell survival. Cells use a protein called the mitochondrial sodium-calcium exchanger (NCLX) to maintain calcium balance within these organelles. Recent research led by Dr. John W. Elrod, a professor at the Lewis Katz School of Medicine at Temple University, along with his team, has uncovered a new regulator of NCLX, named TMEM65. This protein assists in moving calcium out of mitochondria, offering protection against calcium overload, which can damage cells.

Dr. Elrod's research, published online on April 8, 2025, in the journal Nature Metabolism, marks the first characterization of the interaction between TMEM65 and NCLX in mitochondria. The findings point towards potential advancements in developing new therapies for conditions like heart failure and Alzheimer’s disease that involve calcium overload in mitochondria.

The study has gained attention from several media outlets, including ScienceDaily, Medical Xpress, and Healthmedicinet.com, who have highlighted the significance of this discovery in the field of medical research.

###

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS